| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,587 |
11,074 |
$366K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,917 |
3,408 |
$154K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,508 |
1,351 |
$69K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,300 |
1,140 |
$61K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,066 |
884 |
$29K |
| 99385 |
|
230 |
203 |
$12K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
376 |
128 |
$1K |
| 99386 |
|
12 |
12 |
$863.76 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
112 |
67 |
$832.14 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
43 |
33 |
$659.35 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
44 |
30 |
$629.02 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
50 |
44 |
$420.00 |
| 99459 |
|
12 |
12 |
$129.58 |
| 81003 |
|
89 |
67 |
$91.29 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
37 |
27 |
$1.44 |
| 87275 |
|
31 |
18 |
$0.00 |
| 87276 |
|
31 |
18 |
$0.00 |